These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9789708)

  • 1. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.
    Friedman JH; Goldstein S; Jacques C
    Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Friedman J
    Neurology; 1998 Apr; 50(4):1195-6. PubMed ID: 9566437
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group.
    Lancet; 1999 Jun; 353(9169):2041-2. PubMed ID: 10376627
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
    Diraoui S; van Melick EJ; Jansen PA
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
    Factor SA; Friedman JH; Lannon MC; Oakes D; Bourgeois K;
    Mov Disord; 2001 Jan; 16(1):135-9. PubMed ID: 11215574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
    Goetz CG; Blasucci LM; Leurgans S; Pappert EJ
    Neurology; 2000 Sep; 55(6):789-94. PubMed ID: 10993997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of olanzapine in Parkinsonian dopaminergic psychosis].
    Durán-Ferreras E; Chacón-Peña JR; Durán-Quintana JA
    Rev Neurol; 2002 Oct 1-15; 35(7):691-6. PubMed ID: 12389159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
    Marsh L; Lyketsos C; Reich SG
    Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease.
    Ruggieri S; De Pandis MF; Bonamartini A; Vacca L; Stocchi F
    Clin Neuropharmacol; 1997 Jun; 20(3):204-9. PubMed ID: 9197942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.
    Aarsland D; Larsen JP; Lim NG; Tandberg E
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):392-4. PubMed ID: 10440017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.
    Wolk SI; Douglas CJ
    J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
    Sa DS; Lang AE
    Neurology; 2001 Aug; 57(4):747. PubMed ID: 11524507
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
    Rich SS; Friedman JH; Ott BR
    J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].
    Chacón JR; Durán E; Durán JA; Alvarez M
    Neurologia; 2002 Jan; 17(1):7-11. PubMed ID: 11834192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease.
    Breier A; Sutton VK; Feldman PD; Kadam DL; Ferchland I; Wright P; Friedman JH
    Biol Psychiatry; 2002 Sep; 52(5):438-45. PubMed ID: 12242060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.